Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndrome
Biochemical Pharmacology · 2025
DOI: 10.1016/j.bcp.2025.117348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Chun-Yu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoy…. Hauptthemen laut MEDLINE: Receptors, Formyl Peptide, Respiratory Distress Syndrome, Neutrophils, Aspergillus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chang Gung University, Chang Gung Memorial Hospital, National Science and Technology Council.
Abstract (Originalsprache)
Formyl peptide receptor 1 (FPR1), activated by N-formyl peptides, significantly contributes to neutrophil activation and the development of acute respiratory distress syndrome (ARDS). This study showed that butyrolactone I (BLI), a secondary metabolite of Aspergillus terreus, effectively blocks FPR1 and reduces the severity of ARDS. BLI selectively inhibited superoxide anion production, elastase release, cluster of differentiation molecule 11b (CD11b) expression, and chemotaxis in human neutrophils activated by N-formyl peptides derived from bacteria and mitochondria. The FPR1 receptor-binding and molecular docking assays confirmed that BLI acted as an FPR1 inhibitor. Pharmacological experiments demonstrated that BLI selectively inhibited FPR1 downstream signals in human neutrophils, including calcium mobilization and phosphorylation of protein kinase B (Akt), c-Jun N-terminal kinases (JNK), extracellular regulated protein kinases (ERK), and p38 mitogen-activated protein kinases (p38). In a mouse model of ARDS, treatment with BLI reduced neutrophil infiltration, oxidative damage, and levels of elastase and interleukin-1 beta (IL-1β) in the lungs. The fungal compound BLI could serve as a potential treatment for ARDS by blocking FPR1 and reducing neutrophil-induced injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; Graduate Institute of Natural Products, College of Me…
- Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
- Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804, Taiwan.
- Research Center for Chinese Herbal Medicine and Graduate Institute of Health Industry Technology, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan; Department of Medicine, M…
- Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College o…
- Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan; Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; Research Center for Chinese Herba…
Förderung
- Chang Gung University
- Chang Gung Memorial Hospital
- National Science and Technology Council
- Linkou Chang Gung Memorial Hospital
- Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital
Zitieren
APA
Chen, C. Y., Kuo, Y. T., Liaw, C. C., Wang, Y. H., Chang, S. H., Tsai, Y. F., Hsu, K. C., Lin, T. E., & Hwang, T. L. (2025). Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndrome. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117348
Vancouver
Chen CY, Kuo YT, Liaw CC, Wang YH, Chang SH, Tsai YF, et al. Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndrome. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117348
BibTeX
@article{Chen2025,
author = {Chen, Chun-Yu and Kuo, Yu-Ting and Liaw, Chih-Chuang and Wang, Yi-Hsuan and Chang, Shih-Hsin and Tsai, Yung-Fong and Hsu, Kai-Cheng and Lin, Tony Eight and Hwang, Tsong-Long},
title = {Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndrome},
journal = {Biochemical Pharmacology},
year = {2025},
doi = {10.1016/j.bcp.2025.117348}
}
EUVIMED